ACP-204 clinical trials

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

This study is testing a new drug, ACP-204, for people with Lewy body dementia who also experience psychosis (seeing or hearing things that aren't there). It aims to see if the drug is safe and effective in reducing these symptoms.